Cargando…

From gene-specific to function-specific risk stratification in long QT syndrome Type 2: implications for clinical management

[Figure: see text]

Detalles Bibliográficos
Autor principal:	Crotti, Lia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105882/ https://www.ncbi.nlm.nih.gov/pubmed/36857538 http://dx.doi.org/10.1093/europace/euad035

Ejemplares similares

Congenital long QT syndrome
por: Crotti, Lia, et al.
Publicado: (2008)

Genotype-Specific ECG-Based Risk Stratification Approaches in Patients With Long-QT Syndrome
por: Rieder, Marina, et al.
Publicado: (2022)

Erratum: Genotype-specific ECG-based risk stratification approaches in patients with long-QT syndrome
Publicado: (2023)

Congenital Short QT Syndrome
por: Crotti, Lia, et al.
Publicado: (2010)

Genotype- and Sex-Specific QT-RR Relationship in the Type-1 Long-QT Syndrome
por: Couderc, Jean-Philippe, et al.
Publicado: (2012)

Successful Management of a Young Athlete with Type 2 Long QT Syndrome by Genotype-specific Risk Stratification and Bridging Therapy with a Wearable Cardioverter Defibrillator
por: Kojima, Katsumi, et al.
Publicado: (2022)

Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2
por: Giannetti, Federica, et al.
Publicado: (2023)

The impact of age on long QT syndrome
por: Guettler, Norbert, et al.
Publicado: (2019)

COVID-19 treatments, QT interval, and arrhythmic risk: The need for an international registry on arrhythmias
por: Crotti, Lia, et al.
Publicado: (2020)

Acquired Long-QT Syndrome: Mild but Abnormal?
por: Kashiwa, Asami, et al.
Publicado: (2017)

Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3
por: Mazzanti, Andrea, et al.
Publicado: (2016)

The Outcome of Long QT Syndrome: What is the Optimal Therapy?
por: Ban, Ji-Eun
Publicado: (2022)

Multiscale Complexity Analysis of the Cardiac Control Identifies Asymptomatic and Symptomatic Patients in Long QT Syndrome Type 1
por: Bari, Vlasta, et al.
Publicado: (2014)

The compound mutation, a model for acquire long QT syndrome
por: Morita, Hiroshi
Publicado: (2012)

Management of Patients with Long QT Syndrome
por: Cho, Yongkeun
Publicado: (2016)

Management of patients with long QT syndrome
por: Cay, Serkan, et al.
Publicado: (2017)

Improved Clinical Risk Stratification in Patients with Long QT Syndrome? Novel Insights from Multi-Channel ECGs
por: Samol, Alexander, et al.
Publicado: (2016)

Congenital Short QT Syndrome
por: Antzelevitch, Charles, et al.
Publicado: (2004)

QT Adaptation and Intrinsic QT Variability in Congenital Long QT Syndrome
por: Seethala, Srikanth, et al.
Publicado: (2015)

The Long QT Syndrome
por: Vincent, G. Michael
Publicado: (2002)

Precision medicine for long QT syndrome: patient-specific iPSCs take the lead
por: Yu, Yang, et al.
Publicado: (2023)

Risk stratification in therapy-related myelodysplastic syndromes
por: Zeidan, Amer M.
Publicado: (2017)

An Overview of Diagnosis and Management Strategies for Long QT Syndrome
por: Etheridge, Susan P., et al.
Publicado: (2017)

Long QT Syndrome Management during and after Pregnancy
por: Marcinkeviciene, Agne, et al.
Publicado: (2022)

KCNE1 D85N polymorphism — a sex-specific modifier in type 1 long QT syndrome?
por: Lahtinen, Annukka M, et al.
Publicado: (2011)

Distinct electrophysiological and mechanical beating phenotypes of long QT syndrome type 1-specific cardiomyocytes carrying different mutations
por: Kiviaho, Anna L., et al.
Publicado: (2015)

Molecular pathogenesis of long QT syndrome type 2
por: Smith, Jennifer L., et al.
Publicado: (2016)

Molecular pathogenesis of long QT syndrome type 1
por: Wu, Jie, et al.
Publicado: (2016)

The congenital long QT syndrome Type 3: An update
por: Pérez-Riera, Andrés Ricardo, et al.
Publicado: (2017)

Dynamic QT response to cold‐water face immersion in long‐QT syndrome type 3
por: Takahashi, Kazuhiro, et al.
Publicado: (2020)

Modeling Tissue- and Mutation- Specific Electrophysiological Effects in the Long QT Syndrome: Role of the Purkinje Fiber
por: Iyer, Vivek, et al.
Publicado: (2014)

Implications of Individual QT/RR Profiles—Part 1: Inaccuracies and Problems of Population-Specific QT/Heart Rate Corrections
por: Malik, Marek, et al.
Publicado: (2018)

Is exercise-related QT interval shortening with a peaked T wave a specific electrocardiographic finding of pheochromocytoma?
por: Hayashi, Kenshi, et al.
Publicado: (2013)

Clinical utility gene card for: Long-QT syndrome
por: Beckmann, Britt M., et al.
Publicado: (2021)

Risk Prediction in Women With Congenital Long QT Syndrome
por: Goldenberg, Ilan, et al.
Publicado: (2021)

MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes
por: Lee, Yee-Ki, et al.
Publicado: (2020)

QT correction using Bazett’s formula remains preferable in long QT syndrome type 1 and 2
por: Dahlberg, Pia, et al.
Publicado: (2020)

Correction to: Implications of Individual QT/RR Profiles—Part 1: Inaccuracies and Problems of Population-Specific QT/Heart Rate Corrections
por: Malik, Marek, et al.
Publicado: (2019)

Evaluation and Management of Athletes With Long QT Syndrome: An Evolved Paradigm
por: Gomez, Andrew T., et al.
Publicado: (2016)

The diagnosis and management of long QT syndrome based on fetal echocardiography
por: Blais, Benjamin A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ohjqha51mpmikcjkj20u05eshc